Granules at a Glance.

Over the past four decades, we have grown from single paracetamol manufacturing facility to a multi-faceted global pharmaceutical company, delivering safe, cost-effective, and high-quality medicines.

Strategic partnerships, particularly in the United States, and investments in research and development have helped us expand our product offerings to include finished dosages (FDs) and extend operations across India.

Since inception, our actions have aligned with our commitments, embedding responsible practices at every stage from design through delivery

0+

Workforce


0+

Global customers across 80+ countries


0

State-of-the-art manufacturing facilities

Performance Highlights

0%

Absolute reduction in GHG
emissions (Scope 1 & Scope 2)*

0%

Electricity consumption
from renewable sources

0%

Wastewater recycled
and reused

0%

Hazardous waste co-processed

0 MT

GHG emissions avoided

00 kWh

Energy saved

*Represents annual reduction in FY 24 over previous year

11.7%

Workforce female representation

Zero

Confirmed cases
of discrimination

1,200

Students trained through
Pharma Pathshala

31%

Increase in women employees*

14.3%

Increase in community beneficiaries*

10%

New women recruits

*Represents annual reduction in FY 24 over previous year

100%

Employees trained in the
Code of Conduct

50%

Independent Directors

25%

Women in Board

Zero

Customer complaints
on cybersecurity

Zero

Product recalls

Our Sustainability Journey

FY 23-24 marked another crucial milestone in our journey of sustainable value creation.
Over the years, we have achieved remarkable progress, and now we are harnessing
our solid foundations to move closer to our vision.

2008
  • Recognized by CII for implementing 'Environmental Best Practices' at the Gagillapur plant
  • Set a target of Zero Liquid Discharge (ZLD), Zero accident zone, and zero occupational health hazard status
  • Conducted Hazard Analysis and Risk Assessment (HARA) for each manufactured product
2013
  • The Bonthapally facility received the ISO 14001 certification for environmental management and the OHSAS 18001 certification for occupational health safety systems
2014
  • Successful completion of the Social Accountability Audit for the Gagillapur plant
  • Green initiatives through investments in the ZLD at Bonthapally and the Effluent Treatment Plan at Gagillapur
2017
  • Set a compelling vision to empower significant number of individuals through Pharma Pathashala
  • Launched a Self- Directed Team (SDT) program across manufacturing units to nurture skill development
2018
  • Initiated sourcing of electricity from solar power plants
  • Supported local suppliers by sourcing 50%-55% from Telangana
2019
  • Achieved reduction of solid waste generation and specific water consumption by 27% and 23% at Bonthapally API facility
2020
  • Creation of a sustainability team to execute a focused ESG plan
2021
  • Initiated Scope-1 & 2 GHG emission inventorization
2022
  • Foray into Green Molecules Platform through Investment in CZRO Subsidiary
  • Conducted materiality assessment for the first time and identified 13 ESG material topics
2023
  • Conducted comprehensive GHG Inventorization across value chain including subsidiaries
  • Submission of our SBTi net zero commitment
  • United Nations Global Compact (UNGC) Partnership Established
  • Completed PCF analysis for 65% of sales
  • Advanced supplier sustainability program
2024
  • Achieved SBTi validation and approval for both near-term and long-term goals. Aligned with the 1.5°C pathway towards net zero by 2050 or sooner
  • Achieved 1 MW on-site rooftop solar installation at Gagillapur Unit
  • Achieved 69% Renewable Energy share through PPA, Rooftop Solar and I-RECs
2027

2027 TARGETS

  • Energy intensity reduction by 20%
  • Water intensity reduction by 27%
  • 27% reduction in waste to landfill
2030

2030 TARGETS

  • Reduce Scope 1 and Scope 2 absolute emissions by 42%
  • Reduce Scope 3 absolute emission by 42%
  • Sourcing 100% renewable electricity
  • Achieve Zero Waste to Landfill
  • Touch 1 million+ lives through CSR programs
  • Achieve gender pay parity
  • Achieve a 100% increase in women’s employment compared to FY 24
2032

2032 TARGETS

  • Achieve Water Positivity
2050

2050 TARGETS

  • Achieve Net Zero emissions
Our Sustainability
Strategy and Pillars
Environmental Stewardship
Beyond Limits

Our commitment to environmental responsibility drives us to reduce greenhouse gas Inside this section emissions through our 'One Planet, One Purpose' ethos. We’re cutting Scope 1 and 2 emissions at Bonthapally and Gagillapur with renewable energy, biomass conversion, and energy optimization. Focused on achieving net zero, we are tackling Scope 3 emissions, which make up over 80% of our carbon footprint. By investing in solar energy and renewable credits, we are setting ambitious standards for a sustainable future.

Key Highlights

0%

Share of Renewable energy

00 kWh

Energy saved

0%

Wastewater recycled

0%

Hazardous waste co-processed

Climate and Environment

India is the third-largest greenhouse gas emitter in the world, with a large share of emissions from its energy sector and primarily coal-fired power plants.

Read More
GHG Emissions

The pharmaceutical industry generates a significant share of the world's greenhouse gas emissions. Emissions are generated from almost every stage of the pharmaceutical life cycle, including manufacturing, procurement, transportation, packaging, disposal

Read More
Energy Management

Our primary energy consumption comes from coal and furnace oil for steam generation, High-Speed Diesel (HSD) for diesel generator sets and vehicles. Electricity used in operations and corporate offices also forms a substantial part of our energy usage. To address this, we have adopted a twinpronged strategy: optimizing energy consumption and transitioning to cleaner energy sources.

Read More
Water Management

The pharmaceutical industry has a significant water footprint, as water is crucial for manufacturing processes, serving as a raw material, ingredient, and solvent. Research from York University found pharmaceutical contaminants in many rivers worldwide at unsafe levels.

Read More
Waste Management

Responsible disposal of pharmaceutical waste is critical in preventing soil and water contamination. This could eventually cause antibiotic resistance to bacteria living in the sewage and other negative environmental impacts. Furthermore, open disposal of pharmaceutical waste in landfills could lead to potential misuse and unauthorized resale. Contamination of water due to irresponsible disposal could further damage aquatic life severely.

Read More
Breaking Barriers

Our commitment to breaking barriers is reflected in fostering diversity, inclusion, and well-being at Granules. Our women-led production plant in Shamirpet, with 70% women in key roles, showcases our dedication to empowering women. Through initiatives like the Women Mentorship Program and prioritized recruitment, we build leadership opportunities. We also prioritize employee health with awareness sessions, mental health support, and comprehensive healthcare. With focused training and continuous learning, we create an environment where all employees can thrive.

Key Highlights

100%

Return to work rate

Zero

Confirmed cases of discrimination

1400 +

Students trained through Pharma Pathashala

Fostering a Safe and
Equal Workplace

Granules' leadership has consistently prioritized fostering a positive and friendly work environment, ensuring employees confidently approach their daily tasks.

Read More
Prioritizing Our People

People are at the core of Granules. We are committed to fostering an environment that encourages growth, collaboration, and empowerment. Our approach supports colleagues and communities in reaching their full potential, creating meaningful opportunities for engagement and impact.

Read More
Caring for Our People

We are dedicated to enhancing employee well-being, especially in mental health through a dedicated policy and increased access to counseling services.

Read More
Empowering Change,
Impacting Society

We are committed to shaping a better society through impactful healthcare, education, and community development initiatives. From empowering rural youth, supporting critical healthcare services, promoting education, and fostering sports excellence, our efforts aim to uplift communities and contribute to a brighter future.

Read More
Trailblazing Cutting-edge
Pharmaceutical Research

Our sector is characterized by rapidly evolving trends and advancements, highlighted by the recent pandemic and the impact of climate change on health risks. We recognize the need to adapt swiftly to these changes.

Read More
Integrity In Action

Our commitment to integrity drives ethical practices and transparency across Granules. Our Code of Conduct ensures compliance with business ethics, environmental responsibility, and human rights across all interactions. Through our Supplier Sustainability Program, we work with suppliers to reduce emissions and promote sustainability. With regular audits and a robust grievance mechanism, we maintain the highest standards of integrity, fostering trust and accountability throughout our operations.

Key Highlights

25%

Women on the Board

100%

Of our employees received the code of conduct training

Supply Chain Sustainability

The present scenario necessitates an unprecedented urgency to address climate change underscored by IPCC research, calling for immediate transformative actions.

Read More
Business Ethics and Integrity

Granules' code of conduct applies to all stakeholders, including employees, suppliers, and contractors. We urge them to avoid unfair trading practices, irresponsible advertising, corruption, and anti-competitive behavior.

Read More
Data Privacy and Cyber Security

Each year, we aim to significantly enhance our data security practices, targeting zero data privacy and cybersecurity breaches. To achieve this, we will conduct a third-party vulnerability assessment and evaluate IT and OT security gaps.

Read More
Our Sustainability
Goals and Progress

In the final phase of our strategy development, we set clear short, medium, and long-term goals, assessed current state of ESG integration, and developed ambitious sustainability goals.

These goals align with relevant functions and team members in the performance matrix, for annual evaluations, ensuring appropriate rewards and driving actionable progress.

GHG Emissions

Achieve Net Zero Emissions by 2050

Energy

Achieve 100% sourcing renewable electricity by FY 30

Water

Achieve Water Positivity by FY 32

Waste

Achieve Zero waste to landfill by FY 30

Community Impact, Relations and Development

Touch 1 million lives through CSR programs by FY 30

Human Capital Development

Achieve top-quartile performance in L&D parameters within the pharmaceutical industry.

Occupational Health and Safety

Foster a safety-first culture and target zero workplace fatality

Employee Engagement and Employee Well-being Safety

Achieve high employee satisfaction and retention through career growth, wellness, and work-life balance.

Access, Diversity and Inclusion

Double women's employment by 2030 compared to FY24.

Sustainable Procurement

Engage 75% of key suppliers in carbon reduction initiatives by 2028

Sustainability Governance

Embed ESG in governance to ensure compliance, accountability, and sustainable decision-making.

Data Privacy and Cyber Security

Ensure zero data privacy and cyber security breaches

Sustainability Goals

Stakeholder Engagement

We prioritize the importance of engaging key stakeholders for long-term success. Continuous engagement at all organizational levels involves various mechanisms to value insights and monitor outcomes, led by senior leadership and operational teams with the Board’s oversight.

Download Section

Materiality Assessment

Granules conducts a dual materiality assessment that evaluates the impact of environmental, social, and governance (ESG) factors on the Company and the effects of its operations on the broader environment and society.

Download Section

Sustainability Governance

We established a sustainability governance framework that includes a comprehensive induction process covering Granules’ purpose and objectives.

Download Section
2024

BW PharmaWorld Person of the Year Award 2024

2024

Golden Peacock Awards – Winner of Sustainability 2024

2024

ET RE Pharma Awards

2024

CII 25th National Award for Excellence in Energy Management 2024

2023

QMS Integration Award and Quality Culture Transformation Award

2023

Future Ready Organization

2023

TSREDCO Awards TSECA 2023

2023

Most Trusted Brands of India 2023

2023

IGBC Green Factory Buildings – Crusader of Sustainability

2022

Gold and Silver Winner at the 10th CII National Poka-Yoke Competition

Commitments

Sustainability Ratings

Partner Collaboration Platforms